1. Repository of OAI
Ελληνικά   English  

Browsing by Author Tselepis, A. D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 190 to 209 of 255 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with OxLDL and IL-1 beta effectsVerouti, S. N.; Fragopoulou, E.; Karantonis, H. C.; Dimitriou, A. A.; Tselepis, A. D.; Antonopoulou, S.; Nomikos, T.; Demopoulos, C. A.24-Nov-2015-
PAF-acetylhydrolase activity in familial hypercholesterolaemiaTselepis, A. D.; Karabina, S. A. P.; Elisaf, M.24-Nov-2015-
PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietinPapavasiliou, E. C.; Gouva, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
A Paf-Acetylhydrolase Activity in Tetrahymena-Pyriformis CellsTselepis, A. D.; Lekka, M. E.; Tsoukatos, D.24-Nov-2015-
PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitroKarabina, S. A. P.; Elisaf, M. C.; Goudevenos, J.; Siamopoulos, K. C.; Sideris, D.; Tselepis, A. D.24-Nov-2015-
PAF-acetylhydrolase activity on Lp(a) inpatients with acute coronary syndromesTsironis, L. D.; Catsouras, C. S.; Goudevenos, J.; Michalis, L. K.; Sideris, D. A.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
PAF-acetylhydrolase is an antiinflammatory and antioxidant phospholipase A(2) that may be implicated in atherothrombosisTselepis, A. D.; Elisaf, M. S.; Goudevenos, J.; Karabina, S. A.; Tsoukatos, D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Paf-Degrading Acetylhydrolase Is Preferentially Associated with Dense Ldl and Vhdl-1 in Human Plasma - Catalytic Characteristics and Relation to the Monocyte-Derived EnzymeTselepis, A. D.; Dentan, C.; Karabina, S. A. P.; Chapman, M. J.; Ninio, E.24-Nov-2015-
A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin alpha IIb cytoplasmic domain inhibits platelet activationKoloka, V.; Christofidou, E. D.; Vaxevanelis, S.; Dimitriou, A. A.; Tsikaris, V.; Tselepis, A. D.; Panou-Pomonis, E.; Sakarellou-Daitsiotis, M.; Tsoukatos, D. C.24-Nov-2015-
A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin IIb cytoplasmic domain, inhibits platelet activationKoloka, V.; Christofidou, E. D.; Vaxevanelis, S.; Dimitriou, A. A.; Tsikaris, V.; Tselepis, A. D.; Panou-Pomonis, E.; Sakarellos-Daitsiotis, M.; Tsoukatos, D. C.24-Nov-2015-
Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A(2)Lourida, E. S.; Georgiadis, A. N.; Papavasiliou, E. C.; Papathanasiou, A. I.; Drosos, A. A.; Tselepis, A. D.24-Nov-2015-
Patients with early rheumatoid arthritis have elevated autoantibody titers against oxidized forms of LDLLourida, E. S.; Georgiadis, A.; Papathanasiou, A. I.; Voulgari, P.; Drosos, A.; Tselepis, A. D.24-Nov-2015-
Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolaseDentan, C.; Tselepis, A. D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Persistence of an atherogenic lipid profile after treatment of acute infection with brucellaApostolou, F.; Gazi, I. F.; Kostoula, A.; Tellis, C. C.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015-
Phenotype determinants of the thiglycerides lowering effect of rosuvastatinKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Saougos, V. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis proceduresMilionis, H. J.; Elisaf, M. S.; Karabina, S. A.; Bairaktari, E.; Tselepis, A. D.; Siamopoulos, K. C.24-Nov-2015-
Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis proceduresMilionis, H. J.; Elisaf, M. S.; Karabina, S. A. P.; Bairaktari, E.; Tselepis, A. D.; Siamopoulos, K. C.24-Nov-2015-
Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with beta-thalassemiaTselepis, A. D.; Hahalis, G.; Tellis, C. C.; Papavasiliou, E. C.; Mylona, P. T.; Kourakli, A.; Alexopoulos, D. C.24-Nov-2015-
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Plasma PAF-acetylhydrolase(Lp-PLA(2)) activity as a marker of small-dense LDL in subjects at median cardiovascular riskFilippatos, T. D.; Gazi, I.; Kiortsis, D. N.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Showing results 190 to 209 of 255 < previous   next >